We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Ligaclip Prevents Lymphoceles Following Pelvic Lymphadenectomy

By HospiMedica International staff writers
Posted on 05 Oct 2010
Clipping lymph ducts is better than bipolar coagulation at preventing lymphoceles after laparoscopic pelvic lymphadenectomy (LPL), according to a new study.

Researchers at the Catholic University of the Sacred Heart (Rome, Italy) conducted a prospective randomized pilot study that compared the use of the Ligaclip, a product of Ethicon Endo-Surgery (Cincinnati, OH, USA), with bipolar coagulation in preventing lymphoceles after LPL for gynecologic cancer. More...
A total of 30 female patients with gynecologic malignancy (15 patients with endometrial cancer and 15 with cervical cancer) underwent LPL of all lymphatic tissue in the common iliac, external iliac, internal iliac, obturator, and sacral or presacral regions, plus the vascular part of the cardinal ligament in patients with cervical cancer. The women were then assigned to bipolar coagulation to seal lymphatic vessels on one side, while 10-mm titanium Ligaclips were used to compress the lymphatic vessels on the other side.

The researchers found that when a vaginal ultrasound examination was performed six weeks later, lymphocele were present in 10 patients (33%). Lymphocele had developed in 9 (30%) patients on the side where LPL was performed using bipolar coagulation, but in only one patient on the side where it was performed using the Ligaclip. On univariate analysis, the incidence of lymphocele was not related to body mass index, tumor type, other surgical procedures, or number of lymph nodes removed. The only predictor was bipolar coagulation versus Ligaclip use. The study was published ahead of print on August 17, 2010, in the American Journal of Obstetrics & Gynecology.

"This study demonstrates that the use of the Ligaclip to close lymphatic vessels may reduce the incidence of lymphoceles in patients undergoing laparoscopic pelvic lymphadenectomy,” concluded lead author Valerio Gallotta, M.D., and colleagues of the division of gynecologic oncology.

"Since the clip merely mechanically closes the 'tube' or lymph channel, it stands to reason that the clip would be more effective in preventing lymphocele compared to electrocautery,” commented Edward Chekan, M.D., a medical affairs director at Ethicon Endo-Surgery. "In lymph channels there is no blood, so there is little chance to form blood clot by using electrocautery.”

Related Links:

Catholic University of the Sacred Heart
Ethicon Endo-Surgery




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.